ResearcherShenyang Pharmaceutical UniversityActive in the last 2 years
Yanchun Li
Matched on ORCID iD 0009-0009-6479-5088; OpenAlex author ID A5081720398.
Their work
- Papers
- 3 (first author 0, last author 1)
- Trials
- 0
- Grants
- 0
- Collaborators
- 4
2020: 1 paper · 2021: none · 2022: 1 paper · 2023: none · 2024: 1 paper
Papers 3
- Riboflavin protects against pancreatic cancer metastasis by targeting TGF-β receptor 1. Co-author DOI 10.1016/j.bioorg.2024.107274↗
- ASPER-29 suppresses the metastasis of pancreatic cancer cells by dual inhibition of cathepsin-L and cathepsin-S. Last author DOI 10.1016/j.cbi.2022.109811↗
- Discovery of specific HDAC6 inhibitor with anti-metastatic effects in pancreatic cancer cells through virtual screening and biological evaluation. Co-author DOI 10.1016/j.bioorg.2020.103679↗
Closest collaborators
The 4 strongest of 4 ranked by shared papers, trials and grants, with recent and small-team work weighing most.
- Enlong Ma · 3 shared papers, 2020–2024
- Paper Riboflavin protects against pancreatic cancer metastasis by targeting TGF-β receptor 1. DOI 10.1016/j.bioorg.2024.107274↗
- Paper ASPER-29 suppresses the metastasis of pancreatic cancer cells by dual inhibition of cathepsin-L and cathepsin-S. DOI 10.1016/j.cbi.2022.109811↗
- Paper Discovery of specific HDAC6 inhibitor with anti-metastatic effects in pancreatic cancer cells through virtual screening… DOI 10.1016/j.bioorg.2020.103679↗
- Juanping Zhao · 2 shared papers, 2022–2024
- Lei Yuan · 2 shared papers, 2020–2022
- Paper ASPER-29 suppresses the metastasis of pancreatic cancer cells by dual inhibition of cathepsin-L and cathepsin-S. DOI 10.1016/j.cbi.2022.109811↗
- Paper Discovery of specific HDAC6 inhibitor with anti-metastatic effects in pancreatic cancer cells through virtual screening… DOI 10.1016/j.bioorg.2020.103679↗
- Haoxuan Song · 1 shared paper, 2020
How to reach this person
A chain of introductions through people who have published, run trials or held grants together (the fewest links first, then the links with the most shared work). Built from public records only; no contact details are kept.